Clinical Trials
37 trialsNCT05039177 2026-03-25
HERKULES-3
Erasca, Inc.
Phase 1/2 Completed
NCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT04774952 2025-04-15
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Completed
NCT05233098 2025-03-06
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
Completed
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT03077685 2024-06-24
Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
NanOlogy, LLC
Phase 2 Completed
NCT03549494 2024-02-07
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
Phase 2 Completed
NCT03559543 2024-02-07
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT02231723 2023-11-18
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
Sumitomo Pharma America, Inc.
Phase 1 Completed
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT02993731 2023-11-15
CanStem111P
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT04299880 2023-11-08
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
Sumitomo Pharma America, Inc.
Phase 1 Completed
NCT01964430 2023-06-28
apact
Celgene
Phase 3 Completed
NCT03717298 2023-03-28
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT04722055 2022-10-21
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Completed
NCT05374369 2022-07-29
Retrospective Analysis of Colorectal Cancer Screening Results
Creative Biosciences (Guangzhou) Co., Ltd.
Completed
NCT04640792 2022-05-05
A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy
Magentiq Eye LTD
Phase NA Completed
NCT02897778 2022-04-28
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Syndax Pharmaceuticals
Phase 1 Completed
NCT02909452 2022-01-25
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Syndax Pharmaceuticals
Phase 1 Completed
NCT01275222 2021-06-25
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Novartis
Phase 1/2 Completed
NCT03188991 2021-06-14
Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
NanOlogy, LLC
Phase 2 Completed
NCT01681472 2020-09-25
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT01397305 2020-09-09
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT00867113 2018-03-14
Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Novartis
Phase 2 Completed
NCT02141945 2017-03-28
Microbiome Test for the Detection of Colorectal Polyps and Cancer
Metabiomics Corp
Completed
NCT01927965 2017-03-06
Study of Minnelide™ in Patients With Advanced GI Tumors
Minneamrita Therapeutics LLC
Phase 1 Completed
NCT01819766 2017-02-17
OCEANIA
Exact Sciences Corporation
Completed
NCT02503696 2016-08-10
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
Exact Sciences Corporation
Completed
NCT01397747 2015-12-03
DeeP-C
Exact Sciences Corporation
Completed
NCT00879333 2015-11-03
GRANITE-1
Novartis
Phase 3 Completed
NCT01260168 2015-05-13
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Exact Sciences Corporation
Completed
NCT01600209 2015-05-13
Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing
Exact Sciences Corporation
Completed
NCT00666991 2014-02-27
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
CritiTech, Inc.
Phase 1 Completed
NCT01322633 2014-02-20
Risk of Cancer Among Pantoprazole Users
Pfizer
Completed
NCT00969410 2012-04-12
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
AVEO Pharmaceuticals, Inc.
Phase 1 Completed
NCT00392366 2010-01-01
Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis
BioTex, Inc.
Phase NA Completed